Researchers sought to understand patient perspectives relating to their experience, expectations, and preferences of psoriasis treatment.
The FDA has cleared Candesant Biomedical’s Brella™, a SweatControl Patch for the treatment of primary axillary hyperhidrosis in adults.
Arcutis Biotherapeutics has announced the FDA has accepted their NDA for roflumilast foam 0.3% for the treatment of seborrheic dermatitis.
A randomized phase 2 study evaluated the safety, efficacy, and tolerability of IDP-126 in pediatric patients with moderate-to-severe acne.
A group of 10 board-certified dermatologists conducted a Delphi consensus to evaluate the best methods for managing AMH.
The 2023 AAD Annual Meeting was buzzing with exciting news and breakthrough studies. Check out some of the latest clinical updates.
FDA to review supplemental Biologics License Application for Dupixent® (dupilumab) for chronic spontaneous urticaria (CSU).
The LiVDerm team caught up with Natasha A. Mesinkovska, MD, PhD at the 2023 SBS to chat about one of her areas of expertise, alopecia areata.
LiVDerm was honored to speak with Suneel Chilukuri, MD at the 2023 SBS Meeting where he shared his insights on the latest cosmetic devices.
Latanya T. Benjamin, MD has officially been named President-Elect of the Women’s Dermatologic Society.
A full recap of Day Two of the 2023 Masters of Pediatric Dermatology Symposium presented by leading industry experts.
Recent study examines how sarecycline works differently from broad-spectrum antibiotics and how this can be used for future treatments.
A full recap of the 2023 Masters of Pediatric Dermatology Symposium, the incredible two-day event which took place in Miami Beach.
SBS Live Patient Injections Sessions are a hit each year, allowing attendees to pick up valuable tips and tricks from the experts.
The Hot Topics in Aesthetics Session at SBS 2023 took place on day one of the event, led by expert plastic surgeon, Z. Paul Lorenc, MD.
South Beach Symposium (SBS) co-chair, David J. Goldberg, MD, JD, led the Cutaneous Oncology Symposium at this year’s SBS.
Researchers analyze the values and preferences of patients and their caregivers when being treated for atopic dermatitis.
The Boxed Warning Toolkit, a brand-new session at the 2023 South Beach Symposium (SBS) was led by Christopher G. Bunick, MD, PhD
The 2023 SBS featured an in-depth session covering Anti-Aging and Integrative Medicine, including the role of nutrients in skin health.
The 2023 South Beach Symposium (SBS) included a brand-new hot topic, Applications of Genomics and How It Impacts Patient Care.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
